Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Breztri Aerosphere approved in the US for the maintenance treatment of COPD
-
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
-
Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design
-
Brilinta significantly reduced the rate of the composite of stroke and death in patients who had an acute ischaemic stroke or transient ischaemic attack in the Phase III THALES trial
-
Brilinta granted FDA Priority Review for the reduction of subsequent stroke in patients who had an acute ischemic stroke or transient ischemic attack
-
Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer
-
Selumetinib granted orphan drug designation in Japan for neurofibromatosis type 1
-
Breztri Aerosphere significantly reduced rate of moderate or severe COPD exacerbations in Phase III ETHOS trial
-
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
-
Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here